MELATONIN AGONIST TREATMENT

摘要

This invention provides methods of administering (1 R-trans)-N-[[2-(2,3-d ihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide as a melatonin receptor agonist to a human subject to treat or prevent a circadian rhythm disorder or sleep disorder.